KRYS
Price
$136.94
Change
+$4.32 (+3.26%)
Updated
Jun 6 closing price
Capitalization
3.96B
65 days until earnings call
REGN
Price
$493.22
Change
+$10.15 (+2.10%)
Updated
Jun 6 closing price
Capitalization
53.25B
54 days until earnings call
Interact to see
Advertisement

KRYS vs REGN

Header iconKRYS vs REGN Comparison
Open Charts KRYS vs REGNBanner chart's image
Krystal Biotech
Price$136.94
Change+$4.32 (+3.26%)
Volume$265.91K
Capitalization3.96B
Regeneron Pharmaceuticals
Price$493.22
Change+$10.15 (+2.10%)
Volume$1.5M
Capitalization53.25B
KRYS vs REGN Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. REGN commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a StrongBuy and REGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (KRYS: $136.94 vs. REGN: $493.22)
Brand notoriety: KRYS: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 74% vs. REGN: 108%
Market capitalization -- KRYS: $3.96B vs. REGN: $53.25B
KRYS [@Biotechnology] is valued at $3.96B. REGN’s [@Biotechnology] market capitalization is $53.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while REGN’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • REGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than REGN.

Price Growth

KRYS (@Biotechnology) experienced а +8.72% price change this week, while REGN (@Biotechnology) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

REGN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($53.3B) has a higher market cap than KRYS($3.96B). KRYS has higher P/E ratio than REGN: KRYS (32.84) vs REGN (12.54). KRYS YTD gains are higher at: -12.588 vs. REGN (-30.568). REGN has higher annual earnings (EBITDA): 5.53B vs. KRYS (140M). KRYS has less debt than REGN: KRYS (9.66M) vs REGN (2.71B). REGN has higher revenues than KRYS: REGN (14.1B) vs KRYS (333M).
KRYSREGNKRYS / REGN
Capitalization3.96B53.3B7%
EBITDA140M5.53B3%
Gain YTD-12.588-30.56841%
P/E Ratio32.8412.54262%
Revenue333M14.1B2%
Total Cash617MN/A-
Total Debt9.66M2.71B0%
FUNDAMENTALS RATINGS
KRYS vs REGN: Fundamental Ratings
KRYS
REGN
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
5753
PRICE GROWTH RATING
1..100
8465
P/E GROWTH RATING
1..100
9797
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (3) in the Biotechnology industry is significantly better than the same rating for KRYS (70) in the Pharmaceuticals Major industry. This means that REGN’s stock grew significantly faster than KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (46) in the Pharmaceuticals Major industry is somewhat better than the same rating for REGN (100) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than REGN’s over the last 12 months.

REGN's SMR Rating (53) in the Biotechnology industry is in the same range as KRYS (57) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to KRYS’s over the last 12 months.

REGN's Price Growth Rating (65) in the Biotechnology industry is in the same range as KRYS (84) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to KRYS’s over the last 12 months.

REGN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as KRYS (97) in the Pharmaceuticals Major industry. This means that REGN’s stock grew similarly to KRYS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSREGN
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
61%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 19 days ago
61%
Declines
ODDS (%)
Bearish Trend 17 days ago
76%
Bearish Trend 3 days ago
55%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
58%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHPYX16.97N/A
N/A
Diamond Hill Mid Cap Y
JPYUSD0.01N/A
N/A
Japan Yen - United States Dollar
USDNZD1.66N/A
N/A
United States Dollar - New Zealand Dollar
CADRUB56.51N/A
N/A
Canadian Dollar - Russia Ruble
GBPAUD2.09N/A
N/A
United Kingdom Pound - Australian Dollar